Rationale and design of the SENTRY trial: sentinel node and organ-preserving surgery <i>versus</i> segmental resection in stage I colon cancer
Bart CT van de Laar(University Medical Center Groningen), Esther C. J. Consten(University Medical Center Groningen), Daan J. Sikkenk(University Medical Center Groningen), Wouter B. Nagengast(University Medical Center Groningen), Leon M.G. Moons(University Medical Center Utrecht), Matthijs P. Schwartz(Meander Medisch Centrum), Halil Akol(Meander Medisch Centrum), Pieter J. Tanis(Erasmus MC), René Arensman(Meander Medisch Centrum), Wouter H de Vos Tot Nederveen Cappel(Isala), Paul M. Verheijen(Meander Medisch Centrum), Frank Jan Voskens(Meander Medisch Centrum), Henderik L. van Westreenen(Isala)
Cited by 0
Related Papers
Colorectal cancer
|The Lancet|2019|5k
Colorectal polypectomy and endoscopic mucosal resection (EMR): European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline
|Endoscopy|2017|1.1k
Endoscopic or surgical step-up approach for infected necrotising pancreatitis: a multicentre randomised trial
|The Lancet|2017|732
Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Update 2020
|Endoscopy|2020|348
Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial
|The Lancet. Gastroenterology & hepatology|2019|326